Trademark Overview
On Monday, May 19, 2025, a trademark application was filed for HUMAN PHENOTYPE PROJECT with the United States Patent and Trademark Office. The USPTO has given the HUMAN PHENOTYPE PROJECT trademark a serial number of 99191467. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 19, 2025. This trademark is owned by PHENO.AI LTD. The HUMAN PHENOTYPE PROJECT trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Business collaboration services, namely, providing a national computer-based networking web site for health care educators and medical educators to collaborate across disciplines to help improve health care education and medical education; data management and analysis services for healthcare providers and pharmaceutical companies; business research and data analysis services in the field of human health; compilation, systemization and management of longitudinal clinical, genomic, multi-omics and lifestyle data into computer databases for business and research purposes; subscription-based aggregation and licensing of anonymized health research datasets to academic, governmental and commercial entities; business data analysis and statistical reporting services utilizing aggregated phenotypic, imaging and molecular datasets; recruitment, screening, enrollment and retention management of study participants for biomedical, clinical and observational research projects; consultancy in the fie...
Healthcare services, namely, disease management programs, for managing and preventing diseases; clinical research services in the field of chronic conditions; health advisory relating to health care and consultancy services relating to health care focused on chronic disease prevention and treatment
Medical and scientific research in the field of human health, disease profiling, genomics, phenotyping, and multi-omics; software as a service (SaaS) services featuring software for research on health data, genomics, and disease profiling; software as a service (SaaS) services featuring software for collecting and analyzing data in healthcare, life sciences and pharma industries; scientific consultancy and advisory services related to disease research and genetic profiling; data analysis services for optimization of research processes; scientific and technological services, namely compiling and analyzing longitudinal phenotypic, genomic and multi-omics data to develop artificial-intelligence models for disease risk prediction
